Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceutical Chemicals

Canadian chemistry CROs NuChem and OmegaChem to merge

by Michael McCoy
August 19, 2021 | A version of this story appeared in Volume 99, Issue 30

 

A photo of a chemistry lab.
Credit: NuChem
NuChem's chemistry research lab in Saint-Laurent, Quebec

NuChem Sciences has acquired OmegaChem, creating what it says is Canada’s largest contract research organization (CRO) providing drug discovery chemistry. Three Canadian investment companies are putting up a combined $30 million to support the deal. NuChem says it will have 200 scientists and support staffers. Formed in 2011, NuChem employs many chemists who worked at drug firms such as AstraZeneca that closed labs in Quebec.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.